N-(Phosphonoacetyl)-L-Ornithine
- Generic Name
- N-(Phosphonoacetyl)-L-Ornithine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C7H15N2O6P
- CAS Number
- 63446-55-9
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-27
- Last Posted Date
- 2012-12-19
- Lead Sponsor
- Air Force Military Medical University, China
- Target Recruit Count
- 40
- Registration Number
- NCT01440829
- Locations
- 🇨🇳
Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2021-05-10
- Target Recruit Count
- 30
- Registration Number
- NCT01041755
- Locations
- 🇲🇽
Hospital Universitario "José Eleuterio González", Monterrey, Nuevo León, Mexico
Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2009-06-10
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 96
- Registration Number
- NCT00896831
- Locations
- 🇧🇷
Hospital de ClÃnicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath